Search Blog
Categories
November 2013
M T W T F S S
« Oct   Dec »
 123
45678910
11121314151617
18192021222324
252627282930  

Tags

OTIV, SIRI, QGEN and OXGN added to NASDAQ Active Stock Watch List at EPR

admin

By Equity Profile Report

New York, NY – (ACCESSWIRE) – 11/18/2013 — Equity Profile Report initiates its NASDAQ Active Stock Weekly Watch List adding On Track Innovations Ltd. (NASDAQ:OTIV), SIRIUS XM Radio Inc. (NASDAQ:SIRI), Qiagen NV (NASDAQ:QGEN), and OXiGENE, Inc. (NASDAQ:OXGN) 

On Track Innovations Ltd. (NASDAQ:OTIV) a company that designs, develops, and markets contactless microprocessor-based smart card solutions to customers in Africa, Europe, the Far East, the Americas, and Israel is currently up (+4.53%) on 1,664,310 shares traded after On Track Innovations and ABnote have signed an initial business and technical collaboration agreement. On Track Innovations Ltd. (NASDAQ:OTIV) is currently up (+293.75%) from its recent 52-week low, which has prompted Equity Profile Report to add the stock to their NASDAQ Active Stock Watch List and Investor Poll. 

To find out what other Investors are saying about On Track Innovations Ltd. (NASDAQ:OTIV)

Click Here: http://www.equityprofilereport.com/Survey.aspx?stock=OTIV&SubId=AW

SIRIUS XM Radio Inc. (NASDAQ:SIRI) a company that provides satellite radio services in the United States and Canada is currently down (-1.63%) on 5,897,926 shares traded. SIRIUS XM Radio Inc. (NASDAQ:SIRI) is currently down (-7.89%) from its recent 52-week high, which has prompted Equity Profile Report to add the stock to their NASDAQ Active Stock Watch List and Investor Poll.

To find out what other Investors are saying about SIRIUS XM Radio Inc. (NASDAQ:SIRI)

Click Here: http://www.equityprofilereport.com/Survey.aspx?stock=SIRI&SubId=AW 

Qiagen NV (NASDAQ:QGEN) a company that through its subsidiaries, provides sample and assay technologies worldwide is currently down (-1.22%) on 163,285 shares traded after QIAGEN Announced Third Co-Development Program for Companion Diagnostics Paired With Lilly’s Investigational Cancer Compounds. Qiagen NV (NASDAQ:QGEN) is currently down (-1.54%) from its recent 52-week high, which has prompted Equity Profile Report to add the stock to their NASDAQ Active Stock Watch List and Investor Poll. 

To find out what other Investors are saying about Qiagen NV (NASDAQ:QGEN)

Click Here: http://www.equityprofilereport.com/Survey.aspx?stock=QGEN&SubId=AW 

OXiGENE, Inc. (NASDAQ:OXGN) a clinical-stage biopharmaceutical company that develops therapeutics primarily to treat cancer is currently up (+1.85%) on 323,481 shares traded after OXiGENE announced to Present Phase I Data Demonstrating Antitumor Activity of OXi4503 in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndromes. OXiGENE, Inc. (NASDAQ:OXGN) is currently up (+71.43%) from its recent 52-week low, which has prompted Equity Profile Report to add the stock to their NASDAQ Active Stock Watch List and Investor Poll. 

To find out what other Investors are saying about OXiGENE, Inc. (NASDAQ:OXGN)

Click Here: http://www.equityprofilereport.com/Survey.aspx?stock=OXGN&SubId=AW

Equityprofilereport.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities. Through a vast network of IR professionals Equityprofilereport.com is often aware of several large investor awareness campaigns being deployed.Timing is important when trading Small Caps and Penny Stocks.

Simply sign up for free and start receiving exclusive alerts.

Subscribe Here: http://www.equityprofilereport.com/

Disclosure: Equityprofilereport.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit Equityprofilereport.com website, for complete risks and disclosures. 

Contact Info:
Equity Profile Report
editor@Equityprofilereport.com